# 510(k) Summary - Elecsys Vitamin $\beta _ { 1 2 }$ Test System

# Introduction

According to the requirements of 21 CFR 807.92, the following information provides sufficient detail to understand the basis for a determination of substantial equivalence

# Submitter name, address, contact

Roche Diagnostics 9115 Hague Rd Indianapolis IN 46250 (317) 521-3532

Contact person: Randy Johnson

Date prepared: March 20, 2006

# Device name

Proprietary name:

(1) Elecsys Vitamin $\mathbf { B } _ { 1 2 }$ Immunoassay Elecsys Vitamin $\mathbf { B } _ { 1 2 }$ CalSet II (3) Elecsys Vitamin $\mathtt { B } _ { 1 2 }$ CalCheck

Common name:

(1) Vitamin $\mathbf { B } _ { 1 2 }$ Assay Vitamin $\mathrm { B } _ { 1 2 }$ CalSet 3) Vitamin $\mathbf { B } _ { 1 2 }$ CalCheck

Classification name: () Radioassay, Vitamin $\mathbf { B } _ { 1 2 }$ Calibrator, Secondary (3) Single (specified) analyte controls (assayed and unassayed).

Device description

The Elecsys Vitamin $\mathrm { B } _ { 1 2 }$ Assay employs a competitive test principle using intrinsic factor specific for Vitamin $\boldsymbol { \mathrm { B } } _ { 1 2 }$ Vitamin ${ \bf B } _ { 1 2 }$ in the sample competes with the added Vitamin $\mathbf { B } _ { 1 2 }$ labeled with biotin for the binding sites on the ruthenium-labeled intrinsic factor complex. Results are determined via a calibration curve which is instrument-specifically generated by 2-point calibration and a master curve provided via the reagent barcode.

The Elecsys Vitamin $\mathtt { B } _ { 1 2 }$ CalSet II is a lyophilized product consisting of human serum with added Vitamin B12 in two concentration ranges. During manufacture, the analyte is spiked into the matrix at the desired concentration levels.

The Elecsys Vitamin $\mathbf { B } _ { 1 2 }$ CalCheck is a lyophilized product consisting of human serum with added Vitamin $\mathrm { B } _ { 1 2 }$ During manufacture, the analyte is spiked into the matrix at the desired concentration levels.

# Intended use

The Vitamin $\mathtt { B } _ { 1 2 }$ assay is a Binding assay for the in vitro quantitative determination of vitamin $\mathtt { B } _ { 1 2 }$ in human serum and plasma. The electrochemiluminescence immunoassay "ECLIA" is intended for use on the Roche Elecsys 2010 and MODULAR ANALYTICS E170 (Elecsys module) immunoassay analyzers.

Elecsys Vitamin $\mathtt { B } _ { 1 2 }$ CalSet II i  orlti he v Elecsys Vitamin $\mathbf { B } _ { 1 2 }$ assay on the Elecsys 2010 and MODULAR ANALYTICS E170 immunoassay analyzers.

(3For use in the verification of the calibration established by the Elecsys Vitamin $\mathbf { B } _ { 1 2 }$ reagent on Elecsys 2010 and MODULAR ANALYTICS E170 immunoassay analyzers.

# Predicate device

The Elecsys Vitamin $\mathbf { B } _ { 1 2 }$ Test System is equivalent to other devices legally marketed in the United States. We claim equivalence for the following items

For the Vitamin $\mathrm { B } _ { 1 2 }$ assay and the Vitamin $\mathtt { B } _ { 1 2 }$ CalSet II:

The original Elecsys Vitamin $\mathrm { B } _ { 1 2 }$ on the Elecsys 2010 was cleared under K973702.   
In 2001 under K961481/A003, the MODULAR ANALYTICS E170 analyzer was acknowledged by FDA.

For the Vitamin $\mathrm { B } _ { 1 2 }$ CalCheck:

The original Elecsys Vitamin $\mathbf { B } _ { 1 2 }$ CalCheck was cleared under K974383.

# 510(k) Summary - Elecsys Vitamin $\beta _ { 1 2 }$ Test System, Continued

The table below compares the Elecsys Vitamin $\mathbf { B } _ { 1 2 }$ (K973702) and the Elecsys Vitamin $\mathbf { B } _ { 1 2 }$ (modified device).

Device comparison (Reagents)   
Substantial equivalence  similarities   

<table><tr><td rowspan=1 colspan=1>Topic</td><td rowspan=1 colspan=1>Elecsys Vitamin B12(K973702)</td><td rowspan=1 colspan=1>Elecsys Vitamin B12(Modified Device)</td></tr><tr><td rowspan=1 colspan=3>REAGENTS</td></tr><tr><td rowspan=1 colspan=1>Intended use</td><td rowspan=1 colspan=1>Binding assay for the in vitroquantitative determination of vitaminB12 in human serum and plasma. Theelectrochemiluminescenceimmunoassay &quot;ECLIA&quot; is intendedfor use on the Roche Elecsys1010/2010 and MODULARANALYTICS E170 (Elecsys module)immunoassay analyzers.</td><td rowspan=1 colspan=1>Binding assay for the in vitroquantitative determination of vitaminB12 in human serum and plasma. Theelectrochemiluminescenceimmunoassay &quot;ECLIA&quot; is intendedfor use on the Roche Elecsys 2010 andMODULAR ANALYTICS E170(Elecsys module) immunoassayanalyzers.</td></tr><tr><td rowspan=1 colspan=1>Assay Protocol</td><td rowspan=1 colspan=1>Competitive assay</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>DetectionProtocol</td><td rowspan=1 colspan=1>Electrochemiluminescenceimmunoassay</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Measuringrange</td><td rowspan=1 colspan=1>30 -2,000 pg/mL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Analyticalsensitivity(lower detectionlimit)</td><td rowspan=1 colspan=1>30 pg/mL</td><td rowspan=1 colspan=1>Same</td></tr></table>

The table below compares the Elecsys Vitamin $\mathbf { B } _ { 1 2 }$ CalSet (K973702) and the Elecsys Vitamin $\mathbf { B } _ { 1 2 }$ CalSet II (modified device).

Device comparison (Calibrators)   
Substantial equivalence  similarities   

<table><tr><td rowspan=1 colspan=1>Topic</td><td rowspan=1 colspan=1>Elecsys Vitamin B12 CalSet(K973702)</td><td rowspan=1 colspan=1>Elecsys Vitamin B12 CalSet II(Modified Device)</td></tr><tr><td rowspan=1 colspan=3>CALIBRATORS</td></tr><tr><td rowspan=1 colspan=1>Intended use</td><td rowspan=1 colspan=1>Elecsys B12 CalSet is used forcalibrating the quantitative Elecsys B12assay on the Elecsys 2010immunoassay system.</td><td rowspan=1 colspan=1>Elecsys Vitamin B12 CalSet II is usedfor calibrating the quantitative ElecsysVitamin B12 assay on the Elecsys 2010and MODULAR ANALYTICS E170immunoassay analyzers.</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>Two</td><td rowspan=1 colspan=1>Same</td></tr></table>

# 510(k) Summary $\cdot$ Elecsys Vitamin $\beta _ { 1 2 }$ Test System, Continued

The table below compares the Elecsys Vitamin $\mathbf { B } _ { 1 2 }$ CalCheck (K974383) and the Elecsys Vitamin $\mathbf { B _ { 1 2 } }$ CalCheck (modified device).

Device comparison (CalCheck)   
Substantial equivalence — similarities   

<table><tr><td rowspan=1 colspan=1>Topic</td><td rowspan=1 colspan=1>Elecsys Vitamin B12 CalCheck(K974383)</td><td rowspan=1 colspan=1>Elecsys Vitamin B12 CalCheck(Modified Device)</td></tr><tr><td rowspan=1 colspan=3>CALIBRATION VERIFICATION</td></tr><tr><td rowspan=1 colspan=1>Intended use</td><td rowspan=1 colspan=1>For use in the verification of thecalibration established by the ElecsysVitamin B12 reagent and CalSet on theElecsys 2010 immunoassay analyzer.</td><td rowspan=1 colspan=1>For use in the verification of thecalibration established by the ElecsysVitamin B12 reagent on Elecsys 2010and MODULAR ANALYTICS E170immunoassay analyzers.</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>Three</td><td rowspan=1 colspan=1>Same</td></tr></table>

Th table belowpare heiffeencs btween theElecysV $\mathbf { B } _ { 1 2 }$ (K973702) and the Elecsys Vitamin $\mathrm { B } _ { 1 2 }$ (modified device).

Device comparison (Reagents)   
Substantial equivalence - differences   

<table><tr><td rowspan=1 colspan=1>Topic</td><td rowspan=1 colspan=1>Elecsys Vitamin B12(K973702)</td><td rowspan=1 colspan=1>Elecsys Vitamin B12(Modified Device)</td></tr><tr><td rowspan=1 colspan=3>REAGENTS</td></tr><tr><td rowspan=1 colspan=1>Qualitycontrol</td><td rowspan=1 colspan=1>Elecsys PreciControl Universal</td><td rowspan=1 colspan=1>Elecsys PreciControl Anemia 1, 2 and3</td></tr><tr><td rowspan=1 colspan=1>Formulation(PT2)</td><td rowspan=1 colspan=1>Composition of PT2:36 g/L NaOH (0.9 M)</td><td rowspan=1 colspan=1>Composition of PT2:40 g/L NaOH (1.0M)</td></tr><tr><td rowspan=1 colspan=1>Specimencollectionandpreparation</td><td rowspan=1 colspan=1>No additional statement was provided.</td><td rowspan=1 colspan=1>A note was added to this section:Note: Samples with extremely hightotal protein concentrations (e.g.patients suffering from Waldenstrom&#x27;smacroglulinemia) are not suitable foruse in this assay, since they may leadto the formation of protein gel in theassay cup. Processing protein gel maycause a run abort. The critical proteinis dependent upon the individualsample composition. The formation ofprotein gel was seen in samples(spiked with human IgG or humanserum albumin) having a total proteinconcentration of &gt; 160 g/L.</td></tr></table>

The table belo pares the iffences between the lecsys V $\mathrm { B } _ { 1 2 }$ (K973702) and the Elecsys Vitamin $\mathtt { B } _ { 1 2 }$ (modified device).

Device comparison (Reagents), continued   
Substantial equivalence - differences   

<table><tr><td>Topic</td><td colspan="2">Elecsys Vitamin B1z</td><td colspan="2">Elecsys Vitamin B12</td></tr><tr><td></td><td colspan="2">(K973702) REAGENTS</td><td>(Modified Device)</td><td></td></tr><tr><td>Precision</td><td>Elecsys 2010 Within-Run: Human Serum 1: 6.9% 203 pg/mL</td><td rowspan="8"></td><td>Elecsys 2010 Within-Run: 232 pg/mL</td></tr><tr><td>Human Serum 2: 4.2% Human Serum 3: 2.7% Control 1: Control 2: 4.3%</td><td>HS 1: 8.7% HS 2:</td></tr><tr><td>481 pg/mL 1,499 pg/mL 2.8%</td><td>4.4% 818 pg/mL HS 3: 3.0%</td></tr><tr><td>1,119 pg/mL PCA 1: 471 pg/mL</td><td>1,245 pg/mL 8.3% 226 pg/mL</td></tr><tr><td>PCA 2:</td><td>4.0% 610 pg/mL</td></tr><tr><td>PCA 3:</td><td>3.1% 1,369 pg/mL</td></tr><tr><td>Total:</td><td></td></tr><tr><td>Human Serum 1: 7.6% 203 pg/mL HS 1: HS 2:</td><td>9.5% 232 pg/mL</td></tr><tr><td>Human Serum 2: 4.4% 481 pg/mL Human Serum 3: 3.2%</td><td>5.1% 818 pg/mL</td></tr><tr><td>1,499 pg/mL HS 3: 3.2% 1,119 pg/mL</td><td>3.7% 1,245 pg/mL</td></tr><tr><td>PCA 1: 4.6%</td><td>8.0% 226 pg/mL</td></tr><tr><td>471 pg/mL PCA 2:</td><td>5.2% 610 pg/mL</td></tr><tr><td>PCA 3:</td><td>3.4% 1,369 pg/mL</td></tr><tr><td>MODULAR ANALYTICS E170 Within-Run:</td><td>MODULAR ANALYTICS E170</td></tr><tr><td>Human Serum 1: 2.4% 155 pg/mL HS 1:</td><td>Within-Run:</td></tr><tr><td>Human Serum 2: 2.8% 359 pg/mL HS 2:</td><td>1.2% 267 pg/mL</td></tr><tr><td>Human Serum 3: 0.6% 1,162 pg/mL</td><td>2.9% 887 pg/mL HS 3: 1.5% 1,308 pg/mL</td></tr><tr><td>PreciControl U1: 0.9% 667 pg/mL</td><td></td></tr><tr><td>PreciControl U2: 4.3% 399 pg/mL</td><td>PCA 1: 1.7% 308 pg/mL</td></tr><tr><td>PCA 2:</td><td>1.0% 710 pg/mL</td></tr><tr><td>PCA 3:</td><td>0.8% 1,524 pg/mL</td></tr><tr><td>Total: 157 pg/mL</td><td></td></tr><tr><td>Human Serum 1: 6.1% Human Serum 2: 3.6% PreciControl 1: 2.8%</td><td>HS 1: 8.4%</td></tr><tr><td>349 pg/mL HS 2:</td><td>269 pg/mL</td></tr><tr><td>Human Serum 3: 2.2% 1,128 pg/mL</td><td>3.3% 853 pg/mL</td></tr><tr><td>HS 3:</td><td>2.5% 1,261 pg/mL</td></tr><tr><td>671 pg/mL PCA 1: 391 pg/mL PCA 2:</td><td>7.5% 239 pg/mL 3.7% 658 pg/mL</td></tr></table>

Device comparison (Reagents), continued

The table belo cpares he iffencs btween the lecsy Vi $\mathbf { B } _ { 1 2 }$ (K973702) and the Elecsys Vitamin $\mathtt { B } _ { 1 2 }$ (modified device).

Substantial equivalence  differences   

<table><tr><td>Topic</td><td>Elecsys Vitamin B12 (K973702)</td><td>Elecsys Vitamin B12 (Modified Device)</td></tr><tr><td colspan="3">REAGENTS</td></tr><tr><td>Method comparison</td><td>Comparison of the Elecsys Vitamin B12 (y) with a commercially available radiobinding Vitamin B12 assay (x):</td><td>Comparison of the Elecsys Vitamin B12 assay MODULAR ANALYTICS E170 calibrated with the Elecsys Vitamin B12 CalSet(x) versus the MODULAR ANALYTICS E170 calibrated with the</td></tr><tr><td rowspan="4"></td><td>N = 345</td><td>Elecsys Vitamin B12 CalSet II (y): N= 101</td></tr><tr><td>Passing Bablok: y = -9.2 + 1.06x r= 0.977 SD(md68) = 45.7</td><td>Passing Bablok: y = 0.982x - 0.018 r= 0.977 SD(md68)= 8.05</td></tr><tr><td>Linear regression: y = 7.4 +1.02x r = 0.977</td><td>Linear regression: y = 0.968x + 5.77 r= 0.999</td></tr><tr><td>Sy.x = 75.5 Sample concentrations range: 30 - 1,798 pg/mL</td><td>Sy.x = 9.63 Sample concentration range: 49 - 1,691 pg/mL</td></tr></table>

# 510(k) Summary - Elecsys Vitamin $\beta _ { 1 2 }$ Test System, Continued

Device comparison (Reagents), continued

The table beocares he iffncs between hElecsy $\mathbf { B } _ { 1 2 }$ (K973702) and the Elecsys Vitamin $\mathbf { B } _ { 1 2 }$ (modified device).

Substantial equivalence - differences   

<table><tr><td rowspan=1 colspan=1>Topic</td><td rowspan=1 colspan=1>Elecsys Vitamin B12(K973702)</td><td rowspan=1 colspan=1>Elecsys Vitamin B12(Modified Device)</td></tr><tr><td rowspan=1 colspan=3>REAGENTS</td></tr><tr><td rowspan=1 colspan=1>Traceability</td><td rowspan=1 colspan=1>Elecsys Vitamin B12 has beencalibrated against a commerciallyavailable radiobinding Vitamin B12assay.</td><td rowspan=1 colspan=1>This method has been standardizedagainst the Elecsys Vitamin Bi2 assay.</td></tr><tr><td rowspan=1 colspan=1>Stability</td><td rowspan=1 colspan=1>Unopened at 2 - 8°C::Up to the stated expiration dateAfter opening:12 weeks at 2 - 8°COn E170/Elecsys 2010:8 weeks</td><td rowspan=1 colspan=1>Unopened at 2 - 8°C::Up to the stated expiration dateAfter opening at 2 - 8°C:12 weeksOn Elecsys 2010:5 weeksOn MODULAR ANALYTICS E170:5 weeks</td></tr><tr><td rowspan=1 colspan=1>Expected values</td><td rowspan=1 colspan=1>Normal rangeUnited States:243 - 894 pg/mLEurope:197 - 866 pg/mL</td><td rowspan=1 colspan=1>Normal range:United States:211 - 946 pg/mLEurope:191 - 663 pg/mL</td></tr><tr><td rowspan=1 colspan=1>Calibrationverification</td><td rowspan=1 colspan=1>Not necessary. The analyzer&#x27;ssoftware automatically checks thevalidity of the curve and drawsattention to any deviations.</td><td rowspan=1 colspan=1>Section deleted.</td></tr></table>

# 510(k) Summary - Elecsys Vitamin $\beta _ { 1 2 }$ Test System, Continued

The table below compares the differences between the Elecsys Vitamin $\mathbf { B } _ { 1 2 }$ CalSet (K973702) and the Elecsys Vitamin $\mathbf { B } _ { 1 2 }$ CalSet II (modified device).

Device comparison (Calibrator)   
Substantial equivalence - differences   

<table><tr><td rowspan=1 colspan=1>Topic</td><td rowspan=1 colspan=1>Elecsys Vitamin B12 CalSet(K973702)</td><td rowspan=1 colspan=1>Elecsys Vitamin B12 CalSet II(Modified Device)</td></tr><tr><td rowspan=1 colspan=3>CALIBRATOR</td></tr><tr><td rowspan=1 colspan=1>Platform</td><td rowspan=1 colspan=1>To be used on the Elecsys 2010immunoassay analyzer.</td><td rowspan=1 colspan=1>To be used on Elecsys 2010 and theMODULAR ANALYTICS E170immunoassay analyzers.</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Human serum albumin with addedVitamin B12</td><td rowspan=1 colspan=1>Human serum with added Vitamin B12</td></tr><tr><td rowspan=1 colspan=1>Storage form</td><td rowspan=1 colspan=1>Liquid</td><td rowspan=1 colspan=1>Lyophilized</td></tr><tr><td rowspan=1 colspan=1>Filling volume</td><td rowspan=1 colspan=1>1.5 mL</td><td rowspan=1 colspan=1>1.0 mL</td></tr><tr><td rowspan=1 colspan=1>Concentrationranges</td><td rowspan=1 colspan=1>Cal 1:  approximately 100 pg/mLCal 2: approximately 1,500 pg/mL</td><td rowspan=1 colspan=1>Cal 1:  approximately 250 pg/mLCal 2: approximately 1,500 pg/mL</td></tr><tr><td rowspan=1 colspan=1>Stability</td><td rowspan=1 colspan=1>Unopened at 2 - 8°C:Up to the stated expiration dateAfter opening:12 weeks at 2 - 8°COn the analyzer:Up to 5 hours in total</td><td rowspan=1 colspan=1>Unopened at 2 - 8°C:Up to the stated expiration dateAfter reconstitution:At 2 - 8°C: 3 daysAt -20°C: 3 months (freeze onlyonceOn the analyzer at 20 - 25°C:Use only once.</td></tr><tr><td rowspan=1 colspan=1>Traceability</td><td rowspan=1 colspan=1>None listed in the package insert.</td><td rowspan=1 colspan=1>The Elecsys Vitamin B12 assay (Cat.No. 04745736) has been standardizedagainst the Elecsys Vitamin B2 assay(Cat. No. 11820753).</td></tr></table>

The table below compares the differences between the Elecsys Vitamin $\mathrm { B } _ { 1 2 }$ CalCheck (K974383) and the Elecsys Vitamin $\mathbf { B } _ { 1 2 }$ CalCheck (modified device).

Device comparison (Calibration verification)   
Substantial equivalence - differences   

<table><tr><td rowspan=1 colspan=1>Topic</td><td rowspan=1 colspan=1>Elecsys Vitamin B12 CalCheck(K974383)</td><td rowspan=1 colspan=1>Elecsys Vitamin B12 CalCheck(Modified Device)</td></tr><tr><td rowspan=1 colspan=3>CALIBRATION VERIFICATION</td></tr><tr><td rowspan=1 colspan=1>Platform</td><td rowspan=1 colspan=1>To be used on the Elecsys 2010immunoassay analyzer.</td><td rowspan=1 colspan=1>To be used on the Elecsys 2010 andthe MODULAR ANALYTICS E170immunoassay analyzer.</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Buffer matrix with added humanserum albumin.</td><td rowspan=1 colspan=1>Human serum matrix</td></tr><tr><td rowspan=1 colspan=1>Storage</td><td rowspan=1 colspan=1>Liquid</td><td rowspan=1 colspan=1>Lyophilized</td></tr><tr><td rowspan=1 colspan=1>Fill Volume</td><td rowspan=1 colspan=1>1.9 mL</td><td rowspan=1 colspan=1>1.0 mL</td></tr><tr><td rowspan=1 colspan=1>Targetconcentration</td><td rowspan=1 colspan=1>Level 1: Approximately 150 pg/mLLevel 2: Approximately 875 pg/mLLevel 3: Approximately 1,600 pg/mL</td><td rowspan=1 colspan=1>Level 1: ≤ 300 pg/mLLevel 2: SameLevel 3: Same</td></tr><tr><td rowspan=1 colspan=1>Traceability</td><td rowspan=1 colspan=1>None listed in the package insert.</td><td rowspan=1 colspan=1>This method has been standardizedagainst the Elecsys Vitamin B12 assay.</td></tr><tr><td rowspan=1 colspan=1>Stability</td><td rowspan=1 colspan=1>Store unopened at 2 - 8°C:Up to the printed expiration date onthe bottle labels.Stability opened:5 hours at 20-25°C</td><td rowspan=1 colspan=1>Store unopened at 2 - 8°C:Up to the printed expiration date onthe bottles labels.Stability reconstituted:4 hours at 20-25°C</td></tr></table>

# APR 1 0 2006

Mr. Randy J. Johnson   
M.T. (ASCP), Regulatory Affairs Consultant Roche Diagnostics Corp.   
9115 Hague Road   
PO Box 50457   
Indianapolis, IN 46250-0457

Re: k060755 Trade/Device Name: Elecsys Vitamin $\mathbf { B } _ { 1 2 }$ Immunoassay, Calset II and Cacheck Regulation Number: 21 CFR§862.1810 Regulation Name: Vitamin $\mathbf { B } _ { 1 2 }$ test system Regulatory Class: Class II Product Code: CDD, JIT, JJX Dated: March 20, 2006 Received: March 21, 2006

Dear Mr. Johnson:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have bee reclassified in accordance with the provisions of the Federal Food Dru, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class II (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2 -

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0484. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address   
http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

![](images/6aad74bc806f10c5818590b11ed30177a52805823ed1ed5c62c26723cf7e488f.jpg)

Alberto Gutierrez, Ph.D. —   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device Evaluation and Safety   
Center for Devices and Radiological Health

# Indications for Use

510(k) Number (if known): K060755

Device Name: Elecsys Vitamin $\mathtt { B } _ { 1 2 }$ Assay

Indications For Use:

Binding assay for the in vitro quantitative determination of vitamin $\mathrm { B } _ { 1 2 }$ in human serum and plasma The electrochemiluminescence immunoassay "ECLIA" is intended for use on the Roche Elecsys 2010 and MODULAR ANALYTICS E170 (Elecsys module) immunoassay analyzers.

A Vitamin $\mathrm { B } _ { 1 2 }$ test system is a device intended to measure Vitamin $\mathrm { B } _ { 1 2 }$ in serum, plasma. Measurements obtained by this device are used in the diagnosis and treatment of anemias of gastrointestinal malabsorption.

# Indications for Use

510(k) Number (if known): K060755

Device Name: Elecsys Vitamin $\mathrm { B } _ { 1 2 }$ CalSet II

Indications For Use:

Elecsys Vitamin $\mathrm { B } _ { 1 2 }$ CalSet II is used for calibrating the quantitative Elecsys Vitamin $\mathrm { B } _ { 1 2 }$ assay on the Elecsys 2010 and MODULAR ANALYTICS E170 immunoassay analyzers.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Offce of In Vitro Diagnostic Devices (OIVD)

Divisioh Sign-Off   
Office Wf in Vito Diagnostic Device   
Evaluation and Safety   
10) k060755

# Indications for Use

510(k) Number (if known): K060755

Device Name: Elecsys Vitamin $\mathbf { B } _ { 1 2 }$ CalCheck

Indications For Use:

For use in the verification of the calibration established by the Elecsys Vitamin $\mathtt { B } _ { 1 2 }$ reagent on Elecsys 2010 and MODULAR ANALYTICS E170 immunoassay analyzers.